As liver cancer rates and mortality continue to rise, advocacy and policy efforts are important

During a session at the 20th Annual Meeting of the International Society of Gastrointestinal Oncology, Sarah Manes, director of the liver cancer program at the Global Liver Institute, highlighted related unmet needs. to liver cancer and discussed the organization’s mission to advance research and address health disparities. Liver cancer is the sixth most common cancer … Read more

Mixed earnings pull stock market down; Health insurance costs could rise again

Mixed earnings pull stock market down;  Health insurance costs could rise again

Wall Street falters after mixed earnings reports NEW YORK Wall Street fell on October 18 after rising Treasury yields tightened pressure on the stock market and major US companies issued a series of mixed profit reports. Worries about war in the Middle East also pulled the market down. The S&P 500 index fell 1.3% on … Read more

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access | CNN

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access |  CNN

CNN — Prices for the Covid-19 drug Paxlovid will likely rise next year for most patients as the United States continues to move out of the emergency phase of the pandemic, raising concerns among doctors that the drug will become more difficult to reach. Just like this season’s Covid-19 vaccine, the combination antiviral drug nirmatrelvir … Read more

Novo Nordisk warns online offers of fake Ozempic, Wegovy are on the rise

Novo Nordisk warns online offers of fake Ozempic, Wegovy are on the rise

[1/2]A 0.25 mg injection pen of Novo Nordisk’s Wegovy weight loss drug is shown in this illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights Oct 12 (Reuters) – Novo Nordisk (NOVOb.CO) on Thursday warned of a rise in counterfeit versions of weight loss drug Wegovy and diabetes drug Ozempic being … Read more

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access | CNN

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access |  CNN

Stephanie Nano/AP/File Paxlovid will move from making it free to everyone through government purchases to the more traditional commercial market later this year. CNN Prices for the Covid-19 drug Paxlovid will likely rise next year for most patients as the United States continues to move out of the emergency phase of the pandemic, raising concerns … Read more